Biolase Technology, Inc. Class Action Dismissed

A securities class action was filed against the medical technology company alleging securities fraud. The case was filed in the United States District Court for the Central District of California. The class included shareholders who purchased, converted, exchanged or otherwise acquired the common stock of Biolase Technology, Inc. between October 29, 2003 and July 16, 2004. Biolase's motion to dismiss the second amended consolidated class action complaint was granted and the action was dismissed by a United States District Judge. (Jan-18-06) [MARKET WIRE]